Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen

被引:1
作者
Isha, Shahin [1 ]
Olaizola, Gustavo [2 ,3 ]
Bisso, Indalecio Carboni [2 ]
Raavi, Lekhya [1 ]
Jonna, Sadhana [1 ]
Jenkins, Anna [1 ]
Hanson, Abby [1 ]
Kashyap, Rahul [1 ,4 ]
Monzon, Veronica [5 ]
Huespe, Ivan A. [2 ,3 ]
Sanghavi, Devang [1 ]
机构
[1] Mayo Clin, Jacksonville, FL USA
[2] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
[3] Univ Buenos Aires, Buenos Aires, Argentina
[4] Well Span Hlth, York, PA USA
[5] Hosp Italiano Agustin Roca, Buenos Aires, Argentina
关键词
ARDS; coronavirus disease 2019; high-flow nasal cannula oxygen; oxygen saturation; critical care; RESPIRATORY-DISTRESS-SYNDROME;
D O I
10.4187/respcare.11933
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> among non-intubated subjects with ARDS. Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 315 [with S<INF>pO<INF>2</INF></INF> <= 97%] or a P<INF>aO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 300 mm Hg while receiving >= 30 L/min O<INF>2</INF> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> cutoff proposed in the new ARDS definition, and mortality. Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 148, 17% (95% CI 12-23) (n = 38) for those with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> higher than 235 (P < .001). Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [1] High-Flow Nasal Oxygen for Severe Hypoxemia Oxygenation Response and Outcome in Patients with COVID-19
    Ranieri, V. Marco
    Tonetti, Tommaso
    Navalesi, Paolo
    Nava, Stefano
    Antonelli, Massimo
    Pesenti, Antonio
    Grasselli, Giacomo
    Grieco, Domenico Luca
    Menga, Luca Salvatore
    Pisani, Lara
    Boscolo, Annalisa
    Sella, Nicolo
    Pasin, Laura
    Mega, Chiara
    Pizzilli, Giacinto
    Dell'Olio, Alessio
    Dongilli, Roberto
    Rucci, Paola
    Slutsky, Arthur S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (04) : 431 - +
  • [2] High-flow nasal oxygen (HFNO) for patients with Covid-19 outside intensive care units
    Issa, Issa
    Soderberg, Marten
    RESPIRATORY MEDICINE, 2021, 187
  • [3] High-Flow Nasal Cannula and COVID-19: A Clinical Review
    Crimi, Claudia
    Pierucci, Paola
    Renda, Teresa
    Pisani, Lara
    Carlucci, Annalisa
    RESPIRATORY CARE, 2022, 67 (02) : 227 - 240
  • [4] Evaluating the use of the respiratory rate-oxygenation index as a predictor of high-flow nasal cannula oxygen failure in COVID-19
    Weerasuriya, Scott
    Vlachos, Savvas
    Bobo, Ahmed
    Jayaprabhu, Namitha Birur
    Matthews, Lauren
    Blackstock, Adam R.
    Metaxa, Victoria
    ACUTE AND CRITICAL CARE, 2023, 38 (01) : 31 - 40
  • [5] Application of High-Flow Nasal Cannula in COVID-19: A Narrative Review
    Liu, Cheng-Wei
    Cheng, Shih-Lung
    LIFE-BASEL, 2022, 12 (09):
  • [6] Impact of High-Flow Nasal Cannula Use in Subjects With COVID-19 ARDS at High Altitudes: Clinical Presentation and Prognostic Factors
    Molano-Franco, Daniel
    Viruez-Soto, Antonio
    Gomez, Mario
    Beltran, Edgar
    Villabon, Mario
    Sosa, Angela
    Ortiz, Leidy
    Orozco, Estefania
    Hurtado, Alejandra
    Sanchez, Lida
    Arias-Reyes, Christian
    Soliz, Jorge
    Masclans, Joan R.
    RESPIRATORY CARE, 2024, 69 (01) : 99 - 105
  • [7] Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients
    Hultstrom, Michael
    Hellkvist, Ola
    Covaciu, Lucian
    Freden, Filip
    Frithiof, Robert
    Lipcsey, Miklos
    Perchiazzi, Gaetano
    Pellegrini, Mariangela
    CRITICAL CARE, 2022, 26 (01)
  • [8] Prone position combined with high-flow nasal oxygen could benefit spontaneously breathing, severe COVID-19 patients: A case report
    Xu, Da-Wei
    Li, Guang-Liang
    Zhang, Jiong-Han
    He, Fei
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (17) : 4381 - 4387
  • [9] Seriously, Should We Be Treating Severe ARDS With High-Flow Nasal Cannula Oxygen?
    Medina, Alberto
    Modesto i Alapont, Vicent
    RESPIRATORY CARE, 2015, 60 (08) : E148 - E148
  • [10] Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study
    Carlos Ferrando
    Ricard Mellado-Artigas
    Alfredo Gea
    Egoitz Arruti
    César Aldecoa
    Ramón Adalia
    Fernando Ramasco
    Pablo Monedero
    Emilio Maseda
    Gonzalo Tamayo
    María L. Hernández-Sanz
    Jordi Mercadal
    Ascensión Martín-Grande
    Robert M. Kacmarek
    Jesús Villar
    Fernando Suárez-Sipmann
    Critical Care, 24